Breaking News Instant updates and real-time market news.

UA

Under Armour; also tag UAA

$15.12

1.9386 (14.71%)

, ABC

AmerisourceBergen

$99.82

10.37 (11.59%)

09:55
02/13/18
02/13
09:55
02/13/18
09:55

Early notable gainers among liquid option names on February 13th

Notable gainers among liquid option names this morning include Under Armour (UA) $15.36 +2.18, AmerisourceBergen (ABC) $99.55 +10.13, Dun & Bradstreet (DNB) $120.24 +8.56, Martin Marietta (MLM) $227.63 +15.14, and Vulcan Materials (VMC) $130.96 +3.84.

UA

Under Armour; also tag UAA

$15.12

1.9386 (14.71%)

ABC

AmerisourceBergen

$99.82

10.37 (11.59%)

DNB

Dun & Bradstreet

$118.97

7.34 (6.58%)

MLM

Martin Marietta

$227.09

14.33 (6.74%)

VMC

Vulcan Materials

$130.61

3.45 (2.71%)

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 16

    Feb

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

UA Under Armour; also tag UAA
$15.12

1.9386 (14.71%)

02/09/18
JEFF
02/09/18
NO CHANGE
JEFF
Buy
Under Armour discounting down dramatically in last three months, says Jefferies
Jefferies analyst Randal Konik says his firms' February webscrapes point to better traction at Under Armour (UAA) with discounts down in each of the last three months. The company's discounts decreased from 70% in November to 23% in February, down more than 30% year-over-year this month, Konik tells investors in a research note. Further, a survey of 200 footwear retailers shows the Under Armour HOVR Phantom is building momentum, the analyst adds. In addition, the survey shows Nike (NKE) is gaining back share from adidas (ADDYY) in running across the U.S. and Europe. In Basketball, Nike continues to dominate, while Under Armour's Curry 4 is resonating well with consumers, Konik writes. The analyst has a Buy rating on Under Armour and Hold rating on Nike.
02/06/18
JEFF
02/06/18
NO CHANGE
Target $72
JEFF
Hold
Jefferies sees too much management turnover at lululemon
The level of management turnover at lululemon during "this critical juncture in the company's growth trajectory gives us some pause," Jefferies analyst Randal Konik tells investors in a research note following the resignation of CEO Laurent Potdevin. The analyst sees better opportunities elsewhere, namely in shares of Under Armour (UAA), given lululemon's "high" valuation high and "less plentiful" margin opportunity going forward. He maintains a Hold rating on lululemon with a $72 price target.
01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/18
01/16/18
DOWNGRADE
Target $8

Underperform
Under Armour downgraded to Underperform at Macquarie
As previously reported, Macquarie analyst Laurent Vasilescu downgraded Under Armour to Underperform from Neutral and cut its price target to $8 from $10. Vasilescu lowered his FY18 EBIT to $25M from $85M to reflect weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. The analyst expects the credit agreement will need to be amended and expects Under Armour will need a capital raise if gross margins and SG&A continue to deteriorate.
ABC AmerisourceBergen
$99.82

10.37 (11.59%)

02/13/18
LEER
02/13/18
NO CHANGE
LEER
Walgreens may seek to acquire AmerisourceBergen sooner than expected, says Leerink
Leerink analyst David Larsen notes that The Wall Street Journal reported that Walgreens (WBA) has approached AmerisourceBergen (ABC) about a potential takeover. The analyst is surprised that talks of such a large transaction have surfaced so quickly following the Rite Aid (RAD) deal, but says he has always believed that Walgreens at some point would seek to acquire either Express Scripts (ESRX) or AmerisourceBergen. Given the broad-based speculation in the business press about this deal, it is possible shares of Express Scripts will trade off, Larsen contends.
02/13/18
JEFF
02/13/18
NO CHANGE
Target $93
JEFF
Buy
Walgreens deal for AmerisourceBergen would be 'headscratcher,' says Jefferies
Jefferies analyst Brian Tanquilut says that while Walgreens Boots Alliance (WBA) acquiring AmerisourceBergen (ABC) would be accretive to earnings, it would be a "headscratcher" for investors. The companies already have a joint venture that affords both the strategic value that combining would provide, Tanquilut tells investors in a research note after the Wall Street Journal reported that Walgreens approached AmerisourceBergen a few weeks ago. The analyst has a Buy rating on Walgreens with a $93 price target. He adds that the potential deal would allow Walgreens to further expand its U.S. business.
02/13/18
WELS
02/13/18
NO CHANGE
WELS
AmerisourceBergen acquisition by Walgreens makes sense, says Wells Fargo
Commenting on The Wall Street Journal report saying Walgreens (WBA) has approached AmerisourceBergen (ABC) in a takeover attempt and the companies remain early in their discussions, Wells Fargo analyst Peter Costa tells investors he believes the acquisition makes sense given the already existing long-term partnership and limited ability to merge laterally. Further, the analyst believes a potential combination could help lower costs and wring out synergies in the U.S. drug distribution channel, and better position Walgreens in the face of increasing competitive threat from a possible Amazon (AMZN) entry. However, a merger might risk alienating AmerisourceBergen's retail pharmacy customers that compete with Walgreens' pharmacies, he contends.
02/13/18
LOOP
02/13/18
NO CHANGE
Target $90
LOOP
Buy
AmerisourceBergen acquisition by Walgreens would model U.K., says Loop Capital
Loop Capital analyst Andrew Wolf believes that a Walgreens (WBA) and AmerisourceBergen (ABC) full merger would have similar attributes to that of the vertically integrated pharmacy model that Walgreens operates in the U.K. If completed, this transaction would come sooner than the analyst would have anticipated likely spurred by the rapid changes in pharmacy and healthcare occurring around Walgreens. Ultimately, Wolf views this strategic response positively as it would better position a combined company to navigate in the face of industry change and possibly even as a disrupter. He reiterates a Buy rating and $90 price target on Walgreens' shares.
DNB Dun & Bradstreet
$118.97

7.34 (6.58%)

11/13/17
LEHM
11/13/17
UPGRADE
Target $125
LEHM
Equal Weight
Dun & Bradstreet upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Manav Patnai upgraded Dun & Bradstreet to Equal Weight and raised his price target for the shares to $125 from $105. The stock's underperformance has created a steep valuation discount to peers, Patnai tells investors in a research note. He believes the company's best chance for a sustained turnaround is to go private.
11/08/17
GSCO
11/08/17
INITIATION
Target $125
GSCO
Neutral
Dun & Bradstreet initiated with a Neutral at Goldman Sachs
Goldman analyst George Tong initiated Dun & Bradstreet with a Neutral and $125 price target saying shares are fairly valued given choppy new sales performance and slower than expected conversions of mid-market customers to D&B credit.
02/13/18
BARD
02/13/18
NO CHANGE
Target $129
BARD
Outperform
Dun & Bradstreet shares should react positively to CEO departure, says Baird
Baird analyst Jeffrey Meuler said Dun & Bradstreet reported mixed Q4 results, but he expects the shares to react positively to the announcement of the CEO departure. He believes the pace of progress during his tenure was not good considering its spending and the announcement could fuel a potential sale/go private transaction. Meuler reiterated his Outperform rating and $129 price target on Dun & Bradstreet shares.
MLM Martin Marietta
$227.09

14.33 (6.74%)

12/12/17
LEHM
12/12/17
INITIATION
Target $227
LEHM
Equal Weight
Martin Marietta initiated with an Equal Weight at Barclays
Barclays analyst Adam Seiden started Martin Marietta with an Equal Weight rating and $227 price target.
01/17/18
JEFF
01/17/18
NO CHANGE
Target $110
JEFF
Buy
Jefferies names top 2018 picks in Building Products sector
With the U.S. economy strengthening, "big" benefits from tax cuts, and home ownership inflecting, fundamentals remain strong for the Building Products sector, Jefferies analyst Philip Ng tells investors in a research note. The analyst is focused on end markets that have lagged, names with pricing power, and good capital deployment stories. His top picks for 2018 are Owens Corning (OC), Martin Marietta (MLM), Mohawk Industries (MHK) and TopBuild (BLD). Ng raised his price target for Owens to $110, for Martin Marietta to $265, for Mohawk to $345 and for TopBuild to $89.
11/03/17
DADA
11/03/17
NO CHANGE
Target $225
DADA
Neutral
Martin Marietta price target lowered to $225 from $235 at DA Davidson
DA Davidson Brent Thielman lowered his price target on Martin Marietta to $225 and kept his Neutral rating. Thielman says the company will need to show whether easy comps, stable weather and public sector momentum can carry the weight of mid-single digit volume growth guidance in FY18. While the analyst notes some improved activity in Texas and Iowa, he is reducing his price target based on stronger than anticipated challenges of the past year's second half.
02/13/18
RHCO
02/13/18
NO CHANGE
Target $245
RHCO
Buy
Martin Marietta price target raised to $245 from $228 at SunTrust
SunTrust analyst Rohit Seth raised his price target on Martin Marietta to $245 and kept his Buy rating ahead of the company's Q4 earnings. The analyst notes that the adverse weather impact will be balanced by the other favorable trends including industry cement shipments and accelerated construction employment in the company's footprint, along with lower than expected kiln costs.
VMC Vulcan Materials
$130.61

3.45 (2.71%)

10/11/17
JEFF
10/11/17
INITIATION
Target $122
JEFF
Hold
Vulcan Materials assumed with a Hold at Jefferies
Jefferies analyst Philip Ng assumed coverage of Vulcan Materials with a Hold rating and $122 price target. The analyst cites near-term headwinds from Hurricanes Harvey and Irma as well as a "premium valuation" for his Hold rating.
12/12/17
LEHM
12/12/17
INITIATION
Target $135
LEHM
Overweight
Vulcan Materials initiated with an Overweight at Barclays
Barclays analyst Adam Seiden started Vulcan Materials with an Overweight rating and $135 price target.
12/14/17
RHCO
12/14/17
NO CHANGE
Target $145
RHCO
Buy
Vulcan Materials backlog at 3-year-high, says SunTrust
SunTrust analyst Rohit Seth keeps his Buy rating and $145 price target on Vulcan Materials after hosting investor meetings earlier this week. Seth says that "contrary to the contract award data", visibility for the company is on the rise given that the company's backlogs are now at the highest level in 3 years. The analyst adds that Vulcan Materials is gaining confidence that public recovery is underway.
12/26/17
SBSH
12/26/17
NO CHANGE
Target $144
SBSH
Buy
Citi sees 'great stocking stuffer' in Vulcan Materials settlement
Citi analyst Scott Schrier calls Vulcan Materials' settlement with the Justice Department, which allows for the acquisition of Aggregates USA following 17 divestitures, a "great stocking stuffer." The analyst believes there can be "significant synergies" from the deal due to Vulcan's footprint and distribution network in the Southeast part of the country. He keeps a Buy rating on the shares with a $144 price target.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

, SPX

S&P 500

19:25
02/22/18
02/22
19:25
02/22/18
19:25
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Treasury Sec.: Trump…

SPY

SPDR S&P 500 ETF Trust

$270.40

0.35 (0.13%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$41.47

0.33 (0.80%)

19:10
02/22/18
02/22
19:10
02/22/18
19:10
Hot Stocks
OMA Airports reports Q4 passenger traffic up 1.8% »

Total terminal passenger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIV

Aimco

$38.28

0.28 (0.74%)

19:05
02/22/18
02/22
19:05
02/22/18
19:05
Hot Stocks
Aimco acquires Bent Tree apartment community for $160M »

Apartment Investment and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDG

TransDigm

$292.99

0.27 (0.09%)

18:50
02/22/18
02/22
18:50
02/22/18
18:50
Upgrade
TransDigm rating change  »

TransDigm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.60

-0.16 (-4.26%)

18:49
02/22/18
02/22
18:49
02/22/18
18:49
Hot Stocks
Kadmon updates 'positive' results from Phase 2 study of KD025 in cGVHD »

Kadmon announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$182.83

1.49 (0.82%)

18:47
02/22/18
02/22
18:47
02/22/18
18:47
Hot Stocks
Asur reports Q4 passenger traffic down 4% »

ASUR's total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$54.27

-0.83 (-1.51%)

18:45
02/22/18
02/22
18:45
02/22/18
18:45
Periodicals
Judge criticizes U.S. Bancorp deal to sidestep prosecution, Bloomberg reports »

U.S. District Judge Lewis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 30

    May

KZIA

Kazia Therapeutics

$4.99

0.43 (9.43%)

18:36
02/22/18
02/22
18:36
02/22/18
18:36
Hot Stocks
Kazia granted orphan status for glioblastoma treatment »

The FDA granted Kazia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:29
02/22/18
02/22
18:29
02/22/18
18:29
Hot Stocks
Obsidian Energy reports 126% reserve replacement of 2017 production »

Obsidian Energy said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBE

Obsidian Energy

$0.98

0.0183 (1.91%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Hot Stocks
Obsidian Energy names Jay Thornton chairman of the board »

Obsidian Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:27
02/22/18
02/22
18:27
02/22/18
18:27
Earnings
SSR Mining reports Q4 adjusted EPS 2c, consensus 7c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SSRM

SSR Mining

$8.33

0.06 (0.73%)

18:21
02/22/18
02/22
18:21
02/22/18
18:21
Hot Stocks
SSR Mining sees 2018 gold production 340K gold equivalent ounces »

SSR Mining expect to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

IVC

Invacare

$17.97

-0.28 (-1.53%)

18:20
02/22/18
02/22
18:20
02/22/18
18:20
Hot Stocks
Invacare names Kathleen Leneghan as CFO, effective immediately »

Invacare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SHCAY

Sharp

$8.21

-0.025 (-0.30%)

18:18
02/22/18
02/22
18:18
02/22/18
18:18
Periodicals
Sharp drops legal action against Hisense over TV brands, Nikkei reports »

Sharp has dropped legal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$40.91

0.35 (0.86%)

18:17
02/22/18
02/22
18:17
02/22/18
18:17
Periodicals
GM seeks South Korean aid to bolster local unit, Nikkei Asian Review reports »

General Motors is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:14
02/22/18
02/22
18:14
02/22/18
18:14
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

TRTN

Triton International

$28.16

-0.4 (-1.40%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Triton International reports Q4 adjusted EPS 85c, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SJI

South Jersey Industries

$26.34

0.23 (0.88%)

18:13
02/22/18
02/22
18:13
02/22/18
18:13
Earnings
Breaking Earnings news story on South Jersey Industries »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

PAA

Plains All American

$20.97

-0.43 (-2.01%)

18:09
02/22/18
02/22
18:09
02/22/18
18:09
Hot Stocks
Plains All American's Cactus II pipeline fully committed »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

STX

Seagate

$51.36

-0.08 (-0.16%)

18:03
02/22/18
02/22
18:03
02/22/18
18:03
Initiation
Seagate initiated  »

Seagate resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WDC

Western Digital

$85.53

-0.14 (-0.16%)

18:01
02/22/18
02/22
18:01
02/22/18
18:01
Initiation
Western Digital initiated  »

Western Digital resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$21.39

0.22 (1.04%)

17:56
02/22/18
02/22
17:56
02/22/18
17:56
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. sees higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

BKD

Brookdale Senior Living

$7.18

-1.72 (-19.33%)

17:52
02/22/18
02/22
17:52
02/22/18
17:52
Downgrade
Brookdale Senior Living rating change  »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AQMS

Aqua Metals

$2.62

-0.25 (-8.71%)

17:52
02/22/18
02/22
17:52
02/22/18
17:52
Hot Stocks
Philotimo Fund reports 6.5% stake in Aqua Metals »

Philotimo Fund purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$32.31

-0.1271 (-0.39%)

17:47
02/22/18
02/22
17:47
02/22/18
17:47
Earnings
Pembina Pipeline reports Q4 adjusted EPS 99c, consensus 37c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.